prader willi syndrome and glp 1 New commentary offers practical guidance on GLP-1 use in Prader-Willi Prader-Willi syndrome symptoms and signs

While it has been studied over one to two years in clinical trials, there is limited data beyond that time frame, especially regarding: Long-term metabolic effects Nutrient deficiencies due to reduced food intake Potential changes to gut microbiota Dependency on the drug to maintain weight loss Potential changes to gut microbiota Some clinicians have voiced concern that stopping Ozempic can result in rapid weight regain and the return of previous metabolic issues

Some patients report reduced symptoms of inflammation after the very first dose -meaning it cant be due to weight loss or improved insulin sensitivity yet

For example, De Filippis and others have evidenced the cardiovascular health benefits of a diet high in fiber and rich in vegetables and fruits, legumes, and unsaturated fatty acids (Kopp, 2019), A fiber-rich diet promotes the production of acetate macrobiotic, which reduces cardiac hypertrophy and the incidence of CVD

It is often the difference between a successful and a failed protocol

IUBMB Life 71:13471354

Individual preferences, goals, and medical guidance should determine the choice between these peptides